Daphney Zidor, ARNP

Daphney Zidor practices at West Orange Nephrology in Winter Garden, Florida.

Daphney Zidor's NPI, 1982114690, was assigned on October 8, 2017. Daphney Zidor holds Florida license ARNP9308637.

Daphney Zidor's primary practice is West Orange Nephrology, at 301 SW Crown Point Rd, Winter Garden, FL 34787 in Orange County. The practice phone is (407) 297-8408.

Daphney Zidor's primary practice is West Orange Nephrology in Winter Garden, Florida. Daphney Zidor is also affiliated with AdventHealth Orlando. The medical group on file is West Orange Nephrology. Dmand AI also links Daphney Zidor to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daphney Zidor practices, 4 sites in all. Vendor and product names are available with a free account.

Primary care is Daphney Zidor's primary specialty in the NPI Registry, under taxonomy code 363LP2300X. Daphney Zidor is licensed in Florida.

Dmand AI lists chronic diabetes and chronic kidney disease among the conditions Daphney Zidor treats.

CMS data shows 2,026 Medicare services from Daphney Zidor across 6 procedure codes in 2024, for 324 Medicare patients. Medicare paid $144,106 for them. Every service was in an office.

CMS counts 324 Medicare patients who saw Daphney Zidor in 2024. The largest group is 75 to 84, with 114 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daphney Zidor's median patient age at 70, with 56% women.

In 2024, Daphney Zidor wrote 3,208 Medicare Part D claims for 579 patients. 83% of them were for generic drugs. CMS names the drug for 2,917 of them, across 45 drugs with 11 or more claims each, at $461,880 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Daphney Zidor for performance year 2024, reported as part of a group. Daphney Zidor accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Daphney Zidor as offering telehealth.

CMS Open Payments shows 182 general payments to Daphney Zidor from 27 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 92% of the total. Calliditas Therapeutics US Inc. paid the most, $406.